MARKET SUMMERY

DPT stands for diphtheria, pertussis (whooping cough), and tetanus. Market Research Future (MRFR) has published and released a research report about the global DPT vaccine market share that anticipates growth for this market at 7.3% CAGR (Compound Average Growth Rate) between 2022 and 2030. In terms of market value, the worth of global DPT vaccine market has been estimated to be the USD 8342.3 million by the end of the forecast period.

The major factors facilitating the growth of the global DPT vaccine market are increasing deaths in children due to pertussis and increasing awareness about DPT vaccines. The global DPT vaccine market insights has been segmented into application, type, and lastly, region. The application-based segmentation segments this market into diphtheria, pertussis, and tetanus. By type, this market has been segmented into DPaT, DTwP, and Tdap.

Analyzing the market structure, this report offers insights about factors affecting the market growth. Estimating the market size and forecasting the revenue, this reports covers and observes the competitive developments of market players that include mergers and acquisitions, joint ventures, new product developments, research and developments (R&D), and strategic alliances.

KEY PLAYERS

The global DPT vaccine market players include

ü  Chiron Pharmaceutical Pvt Ltd (India),

ü  GSK (USA),

ü  Lanzhou Institute of Biological Products (China),

ü  Merck & Co., Inc (USA),

ü  Sanofi (France), and

ü  Wyeth (USA).

DTP MARKET REGIONAL ANALYSIS

The regional segmentation of the global DPT vaccine market outlook segments the global market into regional markets namely North America, Asia Pacific, Europe, and the Middle East & Africa (MEA). North America is the largest regional market where steady market growth is expected during the forecast period. In this region, the market is growing due to the presence of many important market players in North America, especially in the USA. Other important reasons for market growth in this region are the availability of most advanced medical facilities in this region, emphasis on vaccination against DPT, established healthcare sector, and advanced R&D going on in the medical sector. After the USA, Canada and Mexico are the most important country-specific markets in this region.

Europe is the second largest regional market. The factors encouraging the market growth in this region are a high density of population, established healthcare sector, high level of technological advancement that is second only to North America, and presence of many key market players. The main country-specific markets in this region are the strongest economies known as France, Germany, and the UK, followed by the remaining countries of Europe.

The Asia Pacific is another significant market as healthcare sector is developing in countries like China and India. Advanced medical facilities and rapid technological advancement are available in Japan. The rural market in countries like China and India is still untapped which due to the high density of population can be a lucrative market once tapped into. Aided by the local government and the World Health Organization (WHO), many vaccination programs are being organized in the rural areas of countries like India. During the forecast period, the Asia Pacific region is likely to grow positively.

The MEA region has the least market share due to poor countries, lack of awareness, lack of education, low standard of medical facilities, lack of healthcare facilities, and majority governments not considering healthcare a priority.

Related reports-

Enteral Feeding Devices Market

Transfer Membrane Market

Pharmaceutical Sterility Testing Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America